Article Information
PubMed
Published By
Online ISSN
History
- Received December 13, 2023
- Revision received December 27, 2023
- Accepted December 29, 2023
- Published online February 5, 2024.
Copyright & Usage
© 2024 Boston et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Rebecca H Boston1, Data curation, Formal analysis, Validation, Investigation, Visualization, Writing—original draft, Writing—review and editing,
- Rui Guan1, Data curation, Software, Formal analysis, Visualization, Writing—original draft, Writing—review and editing,
- Lajos Kalmar1, Software, Formal analysis,
- Sina Beier1, Software, Formal analysis,
- Emily C Horner1, Investigation,
- Nonantzin Beristain-Covarrubias1, Investigation,
- Juan Carlos Yam-Puc1, Investigation,
- Pehuén Pereyra Gerber2,3, Resources,
- Luisa Faria1, Investigation, Methodology,
- Anna Kuroshchenkova1, Investigation, Methodology,
- Anna E Lindell1, Investigation, Methodology,
- Sonja Blasche1, Investigation, Methodology,
- Andrea Correa-Noguera4, Resources,
- Anne Elmer5, Resources,
- Caroline Saunders5, Resources,
- Areti Bermperi5, Resources,
- Sherly Jose5, Resources,
- Nathalie Kingston6, Resources,
- CITIID-NIHR COVID-19 BioResource Collaboration*,
- Sofia Grigoriadou7, Resources,
- Emily Staples1, Resources,
- Matthew S Buckland7,8, Resources,
- Sara Lear4, Resources,
- Nicholas J Matheson2,3,9, Resources,
- Vladimir Benes10, Resources, Methodology,
- Christine Parkinson4, Resources,
- James ED Thaventhiran1,4, Conceptualization, Resources, Funding acquisition, Writing—review and editing⇑ and
- Kiran R Patil1, Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing—original draft, Writing—review and editing⇑
- 1Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK
- 2Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK
- 3Department of Medicine, University of Cambridge, Cambridge, UK
- 4Department of Clinical Immunology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
- 5NIHR Cambridge Clinical Research Facility, Cambridge, UK
- 6NIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
- 7Department of Clinical Immunology, Barts Health, London, UK
- 8UCL GOSH Institute of Child Health Division of Infection and Immunity, Section of Cellular and Molecular Immunology, London, UK
- 9NHS Blood and Transplant, Cambridge, UK
- 10European Molecular Biology Laboratory, Heidelberg, Germany
- Correspondence: jedt2{at}mrc-tox.cam.ac.uk
- kp533{at}mrc-tox.cam.ac.uk
↵* CITIID-NIHR COVID-19 BioResource Collaboration members are listed in the below Appendix.
Funding
UK Research and Innovation (UKRI)
MC_UU_00025/11, MC_UU_00025RH Boston, R Guan, L Kalmar, S Beier, EC Horner, N Beristain-Covarrubias, JC Yam-Puc, L Faria, A Kuroshchenkova, AE Lindell, S Blasche, E Staples, JED Thaventhiran, KR Patil
In this Issue
Advertisement
Subjects
Related Articles
Cited By...
- No citing articles found.